Copyright
©The Author(s) 2002.
World J Gastroenterol. Apr 15, 2002; 8(2): 294-297
Published online Apr 15, 2002. doi: 10.3748/wjg.v8.i2.294
Published online Apr 15, 2002. doi: 10.3748/wjg.v8.i2.294
Figure 1 Visualization of hepatitis B-ISCOMS by electron microscopy
Figure 2 Standard curve of Bradford assay
Figure 3 SDS-polyacrylamide gel separation of hepatitis B polypeptide-ISCOMS.
1. Heptatitis B peptide (30)-ISCOMS; 2. ISCOMS matrix; 3. Hepatitis B lipopeptide-ISCOMS; 4. Molecular weight marker; 5. Hepatitis B peptide (30) (as control); 6, 7. Hepatitis B peptide (30)-ISCOMS; 8. Hepatitis B glycopeptide -ISCOMS.
Figure 4 ELISPOT results showing improved specific CTL responses induced by hepatitis B polypeptide incorporated into ISCOMS (B) compared with the polypeptide (A)
- Citation: Guan XJ, Guan XJ, Wu YZ, Jia ZC, Shi TD, Tang Y. Construction and characterization of an experimental ISCOMS-based hepatitis B polypeptide vaccine. World J Gastroenterol 2002; 8(2): 294-297
- URL: https://www.wjgnet.com/1007-9327/full/v8/i2/294.htm
- DOI: https://dx.doi.org/10.3748/wjg.v8.i2.294